Analyst Ratings for Tandem Diabetes Care (TNDM)
TNDM Rating Summary
TNDM Price Target Summary
- Highest: $56.00 (Barclays)
- Lowest: $14.00 (Nephron)
- Average: $27.45
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$27.45 (+29.8%)
* Over Last 12-Mos
Rating Score: 5.2 / 10
Percentile Rank: 56%
Avg. $ Target:
$27.45 (+29.8%)
* Over Last 12-Mos
Rating Score: 5.2 / 10
Percentile Rank: 56%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/23/2026 | Lake Street | Frank Takkinen | Upgrade | Buy (Hold) |
50.00 (N/A) |
24.57 (21.14) |
-13.96% | Details |
| 2/20/2026 | BofA Securities | Travis Steed | Upgrade | Neutral (Underperform) |
30.00 (15.00) |
18.52 (21.14) |
14.15% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
